E. Enerly

发表

miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors

Israel Steinfeld, Zohar Yakhini, Vessela N. Kristensen, 2011, PloS one.

Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.

Vessela N Kristensen, Andrew J. Olson, Ravi Sachidanandam, 2007, Genome research.

Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines

A. Børresen-Dale, S. Leivonen, K. Kleivi, 2009, Oncogene.

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway

R. Lothe, E. Hovig, L. Meza-Zepeda, 2022, Journal of translational medicine.

EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway - A nationwide retrospective cohort study.

Å. Helland, E. Enerly, T. Myklebust, 2022, Cancer treatment and research communications.

NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila.

H. Handa, D. Gilmour, Y. Yamaguchi, 2003, Genes & development.

microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples

R. Lyle, E. Enerly, T. Rounge, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Profiling of the small RNA populations in human testicular germ cell tumors shows global loss of piRNAs

R. Skotheim, E. Enerly, K. Furu, 2015, Molecular Cancer.

Conservation of gene order, structure and sequence between three closely linked genes in Drosophila melanogaster and Drosophila virilis.

E. Enerly, H. Kress, A. Lambertsson, 2002, Gene.

Identification and comparative analysis of the RpL14 gene from Takifugu rubripes.

K. Shalchian-Tabrizi, E. Enerly, H. Ahmadi, 2004, Hereditas.

Evolutionary profiling of the U49 snoRNA gene.

E. Enerly, A. Lambertsson, M. Lyamouri, 2003, Hereditas.

Reverse genetics in drosophila: From sequence to phenotype using UAS‐RNAi transgenic flies

E. Enerly, J. Larsson, A. Lambertsson, 2002, Genesis.

Silencing the Drosophila ribosomal protein L14 gene using targeted RNA interference causes distinct somatic anomalies.

E. Enerly, J. Larsson, A. Lambertsson, 2003, Gene.

p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation

Shalom Madar, Ido Goldstein, Varda Rotter, 2008, Molecular systems biology.

A Human CpG Island Randomly Inserted Into a Plant Genome is Protected From Methylation

F. Larsen, K. Jakobsen, E. Enerly, 2002, Transgenic Research.

EGF Decreases the Abundance of MicroRNAs That Restrain Oncogenic Transcription Factors

Eran Segal, Israel Steinfeld, Zohar Yakhini, 2010, Science Signaling.

An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway

E. Weiderpass, M. Nygård, E. Enerly, 2019, PloS one.

Natural Antisense as Potential Regulator of Alternative Initiation, Splicing and Termination

Zeng Sheng, Kuo-Bin Li, Espen Enerly, 2005, Silico Biol..

Haplotypes associated to gene expression in breast cancer: can they lead us to the susceptibility markers?

A. Tsalenko, A. Frigessi, Z. Yakhini, 2018, bioRxiv.

Prototype precision oncology learning ecosystem: Norwegian precision cancer medicine implementation initiative.

P. Lønning, E. Hovig, B. Gjertsen, 2022, Journal of Clinical Oncology.

A national precision cancer medicine implementation initiative for Norway

Tonje G. Lien, P. Lønning, R. Lothe, 2022, Nature Medicine.

Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway

F. Bray, M. Nygård, E. Enerly, 2011, Acta oncologica.

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

Agust Ingi Agustsson, Maria Hortlund, J. Dillner, 2020, EClinicalMedicine.

Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine

Maria Hortlund, J. Dillner, S. Kjaer, 2015, Clinical and Vaccine Immunology.

Organization, sequence, and phylogenetic analysis of the ribosomal protein S3 gene from Drosophila virilis.

E. Enerly, A. Lambertsson, M. Lyamouri, 2002, Gene.

Monitoring human papillomavirus prevalence in urine samples: a review

M. Nygård, E. Enerly, Cecilia Olofsson, 2013, Clinical epidemiology.

Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme

M. Nygård, E. Enerly, S. Lönnberg, 2016, PloS one.

INSPIRE: A new opportunity for cancer pharmacoepidemiology research

G. Ursin, J. Nygård, E. Enerly, 2021, Norsk Epidemiologi.

Use of real-world data for HPV vaccine trial follow-up in the Nordic region.

Maria Hortlund, A. Saah, L. Tryggvadottir, 2020, Contemporary clinical trials.

Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine

Maria Hortlund, J. Dillner, S. Kjaer, 2015, Clinical and Vaccine Immunology.

Transcription Factors EGF Decreases the Abundance of MicroRNAs That Restrain Oncogenic

I. Amit, Z. Yakhini, A. Børresen-Dale, 2010 .

EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort study.

E. Enerly, T. Myklebust, L. E. Frederiksen, 2023, Cancer treatment and research communications.